LFMD Investors Have Opportunity to Lead LifeMD, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Core Viewpoint - A class action lawsuit has been filed against LifeMD, Inc. for alleged violations of securities laws, claiming the company made false and misleading statements regarding its competitive position and financial guidance [1][4]. Group 1: Lawsuit Details - The lawsuit is based on violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 [1]. - Investors who purchased LifeMD securities between May 7, 2025, and August 5, 2025, are encouraged to participate in the lawsuit [2]. - The class has not yet been certified, meaning potential participants are not currently represented by an attorney [3]. Group 2: Allegations Against LifeMD - The complaint alleges that LifeMD misled investors about its competitive position and raised its fiscal year 2025 performance guidance without proper justification [4]. - The company reportedly ignored critical factors such as customer acquisition costs for weight loss drugs, leading to materially misleading public statements throughout the class period [4]. - As a result of the misleading information, investors suffered damages when the truth about LifeMD was revealed [4].